Your session is about to expire
← Back to Search
Prevention Strategies for Kidney Stones
Study Summary
This trial will compare the effects of two different treatment strategies for kidney stones. The first approach is to give medication to everyone at risk, while the second is to only give medication to those who have already developed stones.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My kidney function is reduced (eGFR<60).I have a blockage in my urinary system that hasn't been treated.I am taking medication like thiazides or topiramate.I have inflammatory bowel disease or have had part of my bowel removed.I am under 18 years old.I have been diagnosed with primary hyperoxaluria.I am 18 years old or older.Your blood test shows low levels of potassium or sodium.I have gout or had 3 gout attacks in the last year.I have had two or more painful kidney stone episodes in the past 5 years.I have been diagnosed with medullary sponge kidney or renal tubular acidosis.I have been diagnosed with primary hyperparathyroidism.I have been diagnosed with sarcoidosis.I have been diagnosed with cystinuria.You have had kidney stones made of certain materials like uric acid, struvite, cystine, or carbonate apatite.
- Group 1: Selective Therapy
- Group 2: Empiric Therapy
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment for this clinical trial currently open?
"Affirmative. Details from clinicaltrials.gov suggest that this trial is still enrolling candidates, having initially been announced on the 4th of August 2022 and last updated the same day. 56 people have to be recruited from 1 medical centre for it to succeed"
Has the FDA officially sanctioned Selective Therapy: Drug?
"Due to Selective Therapy: Drug's status as a Phase 4 trial, our team gave it an overall safety rating of 3; this medication has been officially approved for use."
What is the total number of individuals participating in this experiment?
"Affirmative. According to information on clinicaltrials.gov, this research study is actively recruiting subjects after being first published on August 4th 2022 and last updated the same day. A total of 56 individuals across one site must be enrolled for successful completion of the trial."
Share this study with friends
Copy Link
Messenger